Superficial Basal Cell Carcinoma clinical trials

Explore recruiting superficial basal cell carcinoma clinical trials.

Recruiting superficial basal cell carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Superficial Basal Cell Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Open-label, prospective study evaluating the efficacy and safety of Tirbanibulin 1% (Klisyri®) in the treatment of superficial basal cell carcinoma

France

Phase II and Phase III (Integrated) EU CTIS Study details

Superficial Basal Cell Carcinoma trials by city

Superficial Basal Cell Carcinoma clinical trials

Recruiting superficial basal cell carcinoma studies right now

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia

5-Fluorouracil and Calcipotriene for Treatment of Low Grade Skin Cancer

A Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell Carcinoma

Alpha Radiation Emitters Device (DaRT) for the Treatment of of Malignant Cutaneous Tumors

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.

Also recruiting in Europe

Open-label, prospective study evaluating the efficacy and safety of Tirbanibulin 1% (Klisyri®) in the treatment of superficial basal cell carcinoma

Superficial Basal Cell Carcinoma trials by city

Other conditions